ACTELION Actelion Pharmaceuticals Ltd / Invitation: Actelion to discuss first quarter 2016 financial results . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Dear member of the investment community,
Actelion Ltd will announce its first quarter 2016 financial results on Thursday, 21 April 2016, at 07:00 hrs CEST.
An investor conference call and webcast will be held at 15:00 hrs CEST to discuss the results.
To support your preparations, consensus estimates can be found under www.actelion.com/consensus-estimate
Date/Time:
| 21 April 2016 | 15:00 hrs - 16:00 hrs | Basel |
| 14:00 hrs - 15:00 hrs | London | |
| 09:00 hrs - 10:00 hrs | New York |
Conference Call Connect #:
Dial-in participants should start calling the number below 10-15 minutes before the conference is due to start.
| Dial: | Europe: | +41 (0)44 583 18 01 |
| UK: | +44 (0)203 009 24 53 | |
| US: | +1 855 402 77 68 |
Participant's mode:
Listen-Only with possibility to open individual lines during Q&A session. Participants will be asked for their name and company.
Webcast Access:
Webcast participants should go to the Actelion website http://www.actelion.com 10-15 minutes before the conference is due to start.
Participant's mode: Listen-Only
Webcast Replay:
The archived Investor Webcast will be available for replay through http://www.actelion.com/ approximately 60 minutes after the call has ended.
Actelion Pharmaceuticals Ltd
Investor Relations
Gewerbestrasse 16 | CH-4123 Allschwil | Switzerland | phone +41 61 565 62 62 | fax +41 61 565 65 07
investor.relations@actelion.com | www.actelion.com
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Actelion Pharmaceuticals Ltd via Globenewswire
--- End of Message ---
Actelion Pharmaceuticals Ltd
Gewerbestrasse 16 Allschwil Switzerland
ISIN: CH0010532478;
